A5053195291- Biosimilars and Bioanalytical Methods
- HER2/EGFR in Cancer Research
- Monoclonal and Polyclonal Antibodies Research
- Cancer Treatment and Pharmacology
- Skin Protection and Aging
Libbs (Brazil)
2020-2024
Biological monoclonal antibodies play a pivotal role in cancer treatment, with biosimilars significantly enhancing their accessibility. In Brazil's ethnically diverse setting, real-world evidence is crucial for assessing the effectiveness and applicability of these therapies routine clinical practice.
e12532 Background: The US Food and Drug Administration (FDA) European Medicines Agency (EMA) define a biosimilar as biological molecule product that is highly similar to has no clinically meaningful differences from an existing approved reference product. trastuzumab was the first oncology in Brazil for HER2-positive breast cancer (BC) advanced gastric treatment. This study aimed assess effectiveness safety of (named Zedora Brazil) adjuvant setting among BC patients. Methods: national,...